Page 86 - IMDR JOURNAL 2023-24

IMDR’s Journal of Management Development & Research 2023-24

Information and Technology: Assets are established in IT sector and has a decent system of top-notch
educational organizations.

Globalization: India is dedicated to unrestricted market economy and globalization. The middle-class
marketplace of India constitutes up to 70 million people and has a vertical growth persistently.

Consolidation: The consolidation process, which has become a widespread occurrence in the global pharma
industry, has begun to occur in India as well. There are very good opportunities established in India in the

coming years.

Corporate Profiles:

1. Dr. Reddy’s Laboratory:

The whole time directors of the company Dr. Reddy’s Laboratory are Dr.K.Anjii Reddy (Chairman),
G.V.Prasad (Vice Chairman), and Satish Reddy (Managing Director) respectively. (Source:

www.drredyy’s.com)

Established year of this organization is 1984, Dr. Reddy's Laboratories (NYSE: RDY). This company has three
core businesses:

• Pharmaceutical Services and Active Ingredients
• Global Generics

• Proprietary Products.

2. Ranabaxy laboratory:

Ranbaxy Laboratories Limited, India's largest pharmaceutical company, is an integrated, research-based

international pharmaceutical company, producing a wide range of quality, affordable generic medicines,
trusted by healthcare professionals and patients across the globe. Ranbaxy company is present in the world

market in 49 countries. It also has its topnotch manufacturing amenities in 11 countries, Ranbaxy has its
customers base in an additional 125 countries.

3. Cipla ltd.:

Cipla was established in the year 1937. Cipla was founded by Khwaja Abdul Hamied. Khwaja Abdul Hamied
founded the company of Chemical, Industrial & Pharmaceutical Laboratories, which later came to be known

as CIPLA popularly.

4. Zydus Cadila: